HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A New Homozygous Mutation (c.393-394del TA/c.393-394del TA) in the NT5C3 Gene Associated With Pyrimidine-5'-Nucleotidase Deficiency: A Case Report.

Abstract
Pyrimidine-5-nucleotidase (P5'N-1) deficiency is a rare nonspherocytic hemolytic anemia due to pyrimidine nucleotide deposition within erythrocytes. This rare erythrocyte disorder shows autosomal recessive inheritance with mutation of the pyrimidine-5'-nucleotidase gene, which is localized on 7p15-p14. Consanguinity of parents increases the probability of disease with novel mutations. Here, we report a 12-year-old boy with a delayed diagnosis of P5'N deficiency whose parents were consanguineous. He had a hemoglobin level of 7.5 g/dL, mean corpuscular volume of 93 fL, 7% reticulocyte, and lactate dehydrogenase of 678 IU/L. A peripheral blood smear showed polychromasia, marked anisopoikilocytosis with schistocytes, elliptocytes, stomatocytes, spherocytes, dacryocyte, and basophilic stippling in red blood. Decreased purine/pyrimidine ratio was 1.07 (normal range=1.4 to 2.98). Molecular analysis with direct DNA sequencing of the NT5C3 gene, codifying for P5'N-1, revealed the presence of a novel homozygous mutation, c393-394delTA, in the gene coding P5'N enzyme in the patient. To our knowledge, this is a newly defined mutation in P5'N deficiency.
AuthorsSultan A Köker, Yeşim Oymak, Paola Bianchi, Elisa Fermo, Tuba H Karapinar, Salih Gözmen, Yilmaz Ay, Raziye C Vergin
JournalJournal of pediatric hematology/oncology (J Pediatr Hematol Oncol) Vol. 41 Issue 8 Pg. e484-e486 (Nov 2019) ISSN: 1536-3678 [Electronic] United States
PMID30951028 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Glycoproteins
  • 5'-Nucleotidase
  • NT5C3A protein, human
Topics
  • 5'-Nucleotidase (deficiency, genetics)
  • Anemia, Hemolytic, Congenital (enzymology, genetics)
  • Base Sequence
  • Child
  • Glycoproteins (genetics)
  • Humans
  • Male
  • Sequence Deletion

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: